| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.27 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.23 | 0.007 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.15 | 0.08 |